https://consortiumpublisher.org/index.php/cjas/issue/feed Canadian Journal of Applied Sciences 2022-04-17T18:19:29+00:00 Support Manager support@consortiumpublisher.ca Open Journal Systems <p align="justify"><span style="font-size: 9pt;"> Canadian Journal of Applied Sciences (ISSN: 1925-7430) is an accredited online journal starred in 2011 and. The journal covers a wide range of life and biological sciences and publishes the accepted manuscripts yearly basis. The biological or life sciences comprised of study of life and organisms. Life sciences discoveries are helpful in improving the quality and standard of life, and have applications in health, agriculture, medicine, pharmaceutical and food science industries.</span></p> https://consortiumpublisher.org/index.php/cjas/article/view/769 PREDICTORS OF LATE PRESENTATION OF DIABETIC RETINOPATHY: A MISSED OPPORTUNITY FOR HEALTH SYSTEMS IN PAKISTAN 2022-02-11T17:57:41+00:00 admin consortium admin@consortiumpublisher.ca Saad Alam Khan saadalam04@gmail.com Abdullah Naeem Syed saadalam04@gmail.com Midhet Nasim saadalam04@gmail.com Syed Ali Hasan Naqvi saadalam04@gmail.com Haleema Masud saadalam04@gmail.com <p>Diabetic retinopathy is one of the most common complications of diabetes which can lead to visual impairment or even blindness. However, early detection and prompt treatment can reduce the risk of visual impairment significantly. Therefore, it is important to detect the socioeconomic predictors of late presentation of diabetic retinopathy which was the objective of this study.</p> 2022-02-14T00:00:00+00:00 Copyright (c) 2022 Canadian Journal of Applied Sciences https://consortiumpublisher.org/index.php/cjas/article/view/773 COVID-19 in PAEDIATRIC ONCOLOGY PATIENTS: INCIDENCE AND SEVERITY OF CLINICAL FEATURES IN CANCER VS. NON-CANCER PATIENTS 2022-04-17T18:19:29+00:00 Bakht Jamal bakhtjamal@skm.org.pk Quratulain Zafar quratulain.zafar@skm.org.pk Mir Rooh Ullah Jan roohullahjan@skm.org.pk Muhammad Tahir Aziz tahir@skm.org.pk <p><strong>Introduction: </strong>With the advancements in medical technology, it is now possible to treat deadly diseases like cancer. The drawback of these anticancer treatments is the significantly reduced host’s immune response, which makes these individuals more susceptible to infections. In this study, we analyzed the incidence and clinical features of COVID-19 infections among paediatric cancer patients, and the results were compared to those of non-cancer paediatric patients.</p> <p><strong>Method: This was an observational, retrospective cross-sectional study</strong>. For data gathering, patients' charts were retrospectively analyzed from March 2020 to Feb 2021, and the two groups (COVID-19 infections in paediatric cancer and non-cancer patients) were compared to analyze the incidence and severity of SARS-COV-2 infection and severity of clinical features. The Wilcoxon-Mann-Whitney test was used to compare the means of symptoms and severity of symptoms of two groups, keeping the <em>p</em>-value &lt;0.05 as significant.</p> <p><strong>Result: </strong>Out of the total study population (772), 618 patients were diagnosed with cancer. A total of 53 patients (6.8%) were reported positive for COVID-19, with the break of 35 (5.6%) cancer patients, and 18 (11.7%) non-cancer patients. The mean age of cancer patients with COVID-19 was 7.17 years (range 3-17 years) while of non-cancer patients was 10.6 years (range 2-17 years). 22 patients required hospitalization (62.85%) with an average length of stay of 4.45 days. There was a mortality of one cancer patient with COVID-19. In non-cancer patients, no hospitalization was required with zero mortality.</p> <p><strong>Conclusion: </strong>COVID-19 is more common in the general pediatric population while the infection is more severe in pediatric cancer patients.</p> 2022-04-28T00:00:00+00:00 Copyright (c) 2022 Canadian Journal of Applied Sciences